Jun 01, 2021 7:31 am EDT Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021
Feb 16, 2021 8:00 am EST Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
Jan 12, 2021 5:00 pm EST Immunovant Appoints Rita Jain Chief Medical Officer And Provides Corporate Update
Nov 12, 2020 8:00 am EST Immunovant Reports Financial Results for the Quarter and Six Months Ended September 30, 2020
Sep 04, 2020 4:01 pm EDT Immunovant Announces Closing of $200.0 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares